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ABSTRACT:  
This study examined medication use during long-duration. Medication records from 24 crewmembers on 
20 missions (> 30 days duration) were examined for trends in usage rates, efficacy, indication,  as well as 
adverse event qualities, frequencies and severities. No controls were possible in this observational, 
retrospective analysis of available data; comparisons are made to similar studies of individuals on short-
duration spaceflights and submarine deployments. The most frequently used medications were for sleep 
problems, pain, congestion or allergy. Medication use during spaceflight missions was similar to what is 
seen in adult ambulatory medicine; one notable exception is that usage of sleep aids was about 10 times 
higher in spaceflight. There were also two apparent treatment failures in cases of skin rash, raising 
questions about the efficacy or suitability of the treatments used. Many spaceflight-related medication 
uses were linked to extravehicular-activities and operationally-driven schedule changes. The data suggest 
that sleep and skin rash merit additional study prior to longer space exploration missions. It also seems 
likely that alterations in schedule-shifting or extravehicular activity suits would reduce the need for many 
medication uses, preserving resources as well as improving crew quality of life.  
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